NeuBase Therapeutics, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation (Tables)

Stock-Based Compensation (Tables)

3 Months Ended

Dec. 31, 2020

Schedule of stock-based compensation expense

The Company recorded stock-based compensation expense in the following expense categories of its unaudited condensed consolidated statements of operations for the three months ended December 31, 2020 and 2019:


	Three Months ended December 31,
	2020		2019

General and administrative	$	842,279	$	1,113,111
Research and development		334,306		391,115
Total	$	1,176,585	$	1,504,226

Summary of stock options issued and outstanding

Below is a table summarizing the options issued and outstanding as of and for the three months ended December 31, 2020:


				Weighted
		Weighted		Average	Total
		Average		Remaining	Aggregate
		Exercise		Contractual Life	Intrinsic
	Stock Options	Price		(in years)	Value
Outstanding at September 30, 2020	6,190,790	$	2.76
Granted	494,340		7.42
Exercised	(21,576)		5.21
Forfeited	(30,000)		4.80
Outstanding at December 31, 2020	6,633,554		3.09	8.3	$	27,071,221
Exercisable as of December 31, 2020	4,409,572	$	1.51	8.0	$	24,843,446

Schedule of key assumptions used to estimate the fair value of the stock options granted

Key assumptions used to estimate the fair value of the stock options granted during the three months ended December 31, 2020 and 2019 included:


	Three Months ended December 31,
	2020	2019
Expected term of options (years)	6.0	7.0
Expected common stock price volatility	83.1% - 83.3%	78% - 81.1%
Risk-free interest rate	0.6% - 0.7%	1.7% - 1.8%
Expected dividend yield	—	—

Summary of changes in the outstanding restricted stock

A summary of the changes in the unvested restricted stock during the three months ended December 31, 2020 is as follows:


			Weighted
			Average
			Grant Date
	Unvested Restricted		Fair Value
	Stock		Price
Unvested as of September 30, 2020		—	$	—
Granted		1,931		9.06
Vested		(1,931)		9.06
Unvested as of December 31, 2020		—	$	—